The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease-Reference-Cited by-同舟云学术

The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease

Published:2017-01-01 Issue:1 Volume:42 Page:59-69
ISSN:1180-4882
Container-title:Journal of Psychiatry & Neuroscience
language:
Short-container-title:JPN

Author:

Serrano Mari Paz,Herrero-Labrador Raquel,Futch Hunter S.,Serrano Julia,Romero Alejandro,Fernandez Ana Patricia,Samadi Abdelouahid,Unzeta Mercedes,Marco-Contelles Jose,Martínez-Murillo Ricardo

Publisher

CMA Joule Inc.

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health

Link

https://jpn.ca/wp-content/uploads/2016/12/42-1-59.pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2024-03-10

2. The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy;International Journal of Molecular Sciences;2023-07-31

3. The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases;International Journal of Molecular Sciences;2022-10-04

4. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties;ACS Chemical Neuroscience;2021-12-15

5. Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease;Bioorganic Chemistry;2021-09